Tesomet

DRUG2 trials

Sponsors

Saniona

Conditions

Hypothalamic ObesityPrader-Willi Syndrome

Phase 2

Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO)

WithdrawnNCT05147415

SanionaHypothalamic Obesity

Start: 2021-11-11End: 2022-12-09Updated: 2022-12-13

Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome

WithdrawnNCT05198362

SanionaPrader-Willi Syndrome

Start: 2021-12-28End: 2022-12-09Updated: 2022-12-13